Educational article

Tetracyclines

Tetracyclines interfere with bacterial ribosome function and amino-acid incorporation into a growing protein. Doxycycline, minocycline and newer derivatives differ in spectrum and pharmacokinetics. A shared target does…

Overview

Tetracyclines interfere with bacterial ribosome function and amino-acid incorporation into a growing protein. Doxycycline, minocycline and newer derivatives differ in spectrum and pharmacokinetics. A shared target does not make all members interchangeable.

Biology and practical meaning

Efflux, ribosomal protection and enzymatic inactivation are different resistance mechanisms. A newer derivative may bypass some but not all of them. Clinical breakpoints may be unavailable for particular organism–agent pairs; that gap must not be filled by arbitrary interpretation.

Spectrum, exposure and AST

Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.

Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.

S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.

Teaching example: from finding to conclusion

Teaching example: resistance to one tetracycline is extrapolated to every newer derivative. Ribosomal protection, efflux and inactivation affect molecules differently.

Permitted inference between agents comes from a standard rather than class membership alone. Assuming a newer derivative covers every resistant isolate is the opposite error. Check the exact organism–agent pair and validated method. Missing evidence remains uncertainty rather than an S category.

Sources

Read next

Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.

Open interactive reader